Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 1Phase 2 1

Status

Completed 6

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Dupuytren Contracture 6Contracture 2

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Has results × xiapex × Clear all
NCT01407068 2017-10-05

Administration of Two Injections for Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
60 enrolled 12 charts

Dupuytren Contracture

NCT01498640 2017-10-05

Retreatment of Recurrent Dupuytren's Contractures

Endo Pharmaceuticals

Phase 4 Completed
52 enrolled 15 charts

Contracture, Dupuytren Contracture

NCT01674634 2017-10-05

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
715 enrolled 17 charts

Contracture, Dupuytren Contracture

NCT02193828 2017-10-05

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Endo Pharmaceuticals

Phase 2 Completed
76 enrolled 17 charts

Dupuytren Contracture

NCT01588353 2017-03-21

CORD-J

Asahi Kasei Therapeutics Corporation

Phase 3 Completed
104 enrolled 13 charts

Dupuytren Contracture

NCT01229436 2014-03-17

POINT X

Pfizer

Phase 3 Completed
254 enrolled 28 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡